Kurt C. Sizer
Impact in
- Infectious Diseases top 5%
- Leprosy Research and Treatment
- Tuberculosis Research and Epidemiology
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
Papers in ⓘ
-
- Mycobacterium research and diagnosis 4
- Co-authors
- Xiang Y. Han (4 shared papers)Yiel-Hea Seo (1 shared paper)Nancy F. Olivieri (1 shared paper)Axel Krebs‐Brown (1 shared paper)Romain Séchaud (1 shared paper)David G. Nathan (1 shared paper)Eric Nisbet‐Brown (1 shared paper)Patricia J. Giardina (1 shared paper)
- Journals
- The EMBO Journal (2 papers)Blood (1 paper)Clinical Cancer Research (1 paper)Journal of Bacteriology (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Kurt C. Sizer
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 95
- Infectious Diseases 371
- Genetics 210
- Hematology 220
- Epidemiology 316
- Immunology 134
Countries citing papers authored by Kurt C. Sizer
This map shows the geographic impact of Kurt C. Sizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt C. Sizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt C. Sizer more than expected).
Fields of papers citing papers by Kurt C. Sizer
This network shows the impact of papers produced by Kurt C. Sizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt C. Sizer. The network helps show where Kurt C. Sizer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurt C. Sizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 260 | |
| 2 | 2008 | 188 | |
| 3 | 2000 | 115 | |
| 4 | 2009 | 71 | |
| 5 | 1985 | 66 | |
| 6 | 1985 | 62 | |
| 7 | 2012 | 62 | |
| 8 | 1990 | 56 | |
| 9 | Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. | 2012 | 36 |
| 10 | 2005 | 29 | |
| 11 | 1986 | 24 | |
| 12 | 1983 | 23 | |
| 13 | Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin. | 1984 | 22 |
| 14 | 2010 | 18 | |
| 15 | 1994 | 14 | |
| 16 | 2007 | 9 | |
| 17 | 2001 | 3 | |
| 18 | A PK-PD dose optimization strategy for the microtubule stabilizing agent ABJ879 | 2004 | 1 |
| 19 | 2005 | 1 | |
| 20 | 2008 | 1 |
About Kurt C. Sizer
Kurt C. Sizer is a scholar working on Epidemiology, Molecular Biology, Hematology, Infectious Diseases and Surgery, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (4 papers), Leprosy Research and Treatment (4 papers), Iron Metabolism and Disorders (2 papers), Tuberculosis Research and Epidemiology (2 papers), Blood transfusion and management (2 papers), Erythropoietin and Anemia Treatment (2 papers), Infectious Diseases and Tuberculosis (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (371 citations), Genetics (210 citations), Hematology (220 citations), Epidemiology (316 citations) and Immunology (134 citations). Kurt C. Sizer has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Xiang Y. Han, Yiel-Hea Seo, Nancy F. Olivieri, Axel Krebs‐Brown, Romain Séchaud, David G. Nathan, Eric Nisbet‐Brown, Patricia J. Giardina, Wěi Li and Taylor J. Schoberle. Their work appears in journals such as The EMBO Journal, Blood, Clinical Cancer Research, Journal of Bacteriology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.